Entering text into the input field will update the search result below

SteadyMed nabs European patent protecting infusion-site pain reduction aspect of PatchPump; shares up 3%

Oct. 12, 2017 10:15 AM ETSteadyMed (STDY) StockBy: Douglas W. House, SA News Editor
  • The European Patent Office issues a Notice of Allowance to SteadyMed (NASDAQ:STDY +3.1%) related to claims of infusion-site pain reduction via the delivery of a topical anaesthetic through the underside of its PatchPump infusion system for drugs administered subcutaneously.
  • The company's patent application was No. 13720085.3.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
STDY--
SteadyMed